Educational Activities Archives

Motivational interviewing (MI) is an evidence-based approach to guide and enhance conversations when working with patients to promote positive behavior change. Originally developed in the context of treating substance use disorders, MI is a collaborative method of communication that pays particular attention to the language of change. MI helps to strengthen intrinsic motivation for change by exploring the patient’s own reasons for change by communicating the spirit of acceptance, partnership, empowerment, and compassion. This educational activity will introduce key MI concepts, including the four tasks, the spirit of MI, and skills for evoking change talk.

Understanding addiction is essential to successfully addressing it. In this overview of substance use disorders, we discuss the spectrum of use, neurobiological responses to substances, theories that explain the disorders, public health impact and epidemiology, comorbidity, and integrated care for this chronic condition.

Other substance use disorders can often co-occur with opioid use disorder (OUD). These can include benzodiazepines and other tranquilizers, cocaine and stimulants, and cannabis. Alcohol and nicotine are also considered commonly used substances alongside opioids. In this educational activity, these other substances will be reviewed leading to a discussion of principles of diagnosis and evaluation of treatment for each substance by themselves, and in the context of OUD.

Explore how to effectively address the association SUD and OUD to improve care for individuals at risk for and/or experiencing co-occurring SUD and suicidality. Attendees will hear from two leading experts in suicide prevention and behavioral health.

Co-occurring psychiatric conditions are frequently seen in patients with substance use disorders. Clinicians should be alert to the signs and symptoms of common psychiatric disorders and should understand how to distinguish independent psychiatric disorders from substance-induced disorders. Depressive disorders and anxiety disorders, including post-traumatic stress disorder, are the most common co-occurring conditions, though ADHD is often encountered across the range of substance use disorders. Substance use disorder patients with co-occurring psychiatric disorders will respond to most standard psychological and pharmacological treatments for these psychiatric conditions, though clinicians should avoid the use of scheduled medications and must always focus on sobriety as a primary treatment goal. Treatment that integrates addiction and psychiatric care is the most effective.

This webinar will explore the intersection of substance use and veteran status, examining the impact of post-traumatic stress, moral injury, and systemic barriers to care. Participants will learn about evidence-based interventions, and resources available to veterans.